Sisram Medical Ltd (HKG:1696)
4.290
+0.100 (2.39%)
Mar 12, 2025, 4:08 PM HKT
Sisram Medical Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Net Income | 23.55 | 31.5 | 40.17 | 31.25 | 13.34 | 20.79 | Upgrade
|
Depreciation & Amortization | 16.86 | 14.24 | 12.4 | 12.29 | 10.46 | 9.73 | Upgrade
|
Loss (Gain) From Sale of Assets | - | - | - | - | - | 0.25 | Upgrade
|
Loss (Gain) on Equity Investments | 0.42 | 0.42 | 0.52 | 0.31 | - | - | Upgrade
|
Stock-Based Compensation | 0.49 | 0.49 | 3.17 | 0.29 | - | - | Upgrade
|
Provision & Write-off of Bad Debts | 1.14 | 1.14 | 0.56 | 1.4 | 1.45 | 0.7 | Upgrade
|
Other Operating Activities | 4.31 | 3.04 | 6.46 | 8.74 | 3.84 | 1.19 | Upgrade
|
Change in Accounts Receivable | -3.79 | -3.79 | -16.24 | -23.36 | -2.04 | -14.72 | Upgrade
|
Change in Inventory | -4.08 | -4.08 | -19.36 | -19.44 | -5.57 | -4.97 | Upgrade
|
Change in Accounts Payable | -5.47 | -5.47 | 0.83 | 0.89 | -2.55 | 2.94 | Upgrade
|
Change in Unearned Revenue | 1.78 | 1.78 | 0.07 | 5.75 | 2.23 | 1.9 | Upgrade
|
Change in Other Net Operating Assets | 4.68 | 4.68 | -6.54 | 14.27 | 4.56 | 3.24 | Upgrade
|
Operating Cash Flow | 39.89 | 43.94 | 22.04 | 32.38 | 25.74 | 21.04 | Upgrade
|
Operating Cash Flow Growth | 106.05% | 99.36% | -31.93% | 25.80% | 22.34% | 29.57% | Upgrade
|
Capital Expenditures | -6.61 | -8.57 | -4.75 | -2.97 | -9.27 | -3.17 | Upgrade
|
Sale of Property, Plant & Equipment | 0.07 | 0.01 | 0.04 | - | 0.18 | - | Upgrade
|
Cash Acquisitions | 27.26 | - | - | -43.27 | - | - | Upgrade
|
Sale (Purchase) of Intangibles | -0.16 | - | -59.57 | - | - | - | Upgrade
|
Investment in Securities | 0.31 | -3.31 | 15.96 | 3.88 | -25.17 | 54.97 | Upgrade
|
Other Investing Activities | -20.41 | -21.13 | -3.79 | -4.42 | 0.76 | 1.89 | Upgrade
|
Investing Cash Flow | 0.46 | -33 | -52.11 | -46.77 | -33.51 | 53.69 | Upgrade
|
Short-Term Debt Issued | - | 4.44 | 5.89 | 3.08 | - | - | Upgrade
|
Long-Term Debt Issued | - | - | - | - | 0.1 | 1 | Upgrade
|
Total Debt Issued | 5.38 | 4.44 | 5.89 | 3.08 | 0.1 | 1 | Upgrade
|
Short-Term Debt Repaid | - | -5.68 | -6.97 | -5.18 | - | - | Upgrade
|
Long-Term Debt Repaid | - | -5.97 | -4.98 | -4.63 | -5.28 | -4.99 | Upgrade
|
Total Debt Repaid | -11.93 | -11.65 | -11.96 | -9.81 | -5.28 | -4.99 | Upgrade
|
Net Debt Issued (Repaid) | -6.55 | -7.21 | -6.06 | -6.74 | -5.19 | -3.99 | Upgrade
|
Issuance of Common Stock | - | - | - | 79.18 | - | - | Upgrade
|
Common Dividends Paid | -10.51 | -10.51 | -9.33 | -4.19 | -6.27 | -5.63 | Upgrade
|
Other Financing Activities | -1.72 | -3.24 | -2.46 | -12.47 | -0.75 | 0.27 | Upgrade
|
Financing Cash Flow | -18.78 | -20.97 | -17.85 | 55.78 | -12.21 | -9.36 | Upgrade
|
Foreign Exchange Rate Adjustments | -3.36 | -4.23 | -2.21 | 0.16 | 3.62 | 0.53 | Upgrade
|
Net Cash Flow | 18.21 | -14.26 | -50.13 | 41.55 | -16.36 | 65.9 | Upgrade
|
Free Cash Flow | 33.28 | 35.37 | 17.29 | 29.41 | 16.46 | 17.87 | Upgrade
|
Free Cash Flow Growth | 157.70% | 104.62% | -41.23% | 78.66% | -7.85% | 19.34% | Upgrade
|
Free Cash Flow Margin | 9.34% | 9.84% | 4.88% | 9.99% | 10.16% | 10.30% | Upgrade
|
Free Cash Flow Per Share | 0.07 | 0.08 | 0.04 | 0.06 | 0.04 | 0.04 | Upgrade
|
Cash Interest Paid | 0.64 | 0.49 | 0.43 | 0.39 | 0.43 | 0.33 | Upgrade
|
Cash Income Tax Paid | 8.48 | 7.89 | 8.41 | 7.54 | 1.47 | 2.44 | Upgrade
|
Levered Free Cash Flow | 24.88 | 24.36 | -42.56 | 4.23 | 27.56 | 15.85 | Upgrade
|
Unlevered Free Cash Flow | 26.35 | 25.65 | -41.48 | 5.48 | 28.23 | 16.3 | Upgrade
|
Change in Net Working Capital | 3.54 | 4.28 | 21.1 | 30.86 | -16.66 | 5.08 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.